Photo: Business Wire
“Manage and store results effortlessly with the free app ‘Clearblue me.'”
Clearblue, a well-known brand for its pregnancy tests, has recently introduced a groundbreaking product aimed at addressing the needs of women experiencing menopause. The company’s innovative “Menopause Stage Indicator” is a urine testing device specifically designed for this underserved market in women’s health. By measuring follicle-stimulating hormone (FSH) levels instead of pregnancy hormones, this test can accurately confirm the stage of menopause a person is in.
The Menopause Stage Indicator resembles a standard pregnancy test stick and requires users to conduct five urine tests over a ten-day period, with tests recommended to be taken every other day. By analyzing FSH levels, menstrual cycle history, and age, Clearblue’s app can determine and confirm the menopause stage, categorizing individuals as premenopausal, early perimenopausal, late perimenopausal, or postmenopausal.
Clearblue has emphasized that only healthcare professionals can provide an official confirmation of someone’s menopause stage. However, the app allows users to generate a personalized report that can be shared with their healthcare provider to discuss test results and potential treatment options.
The Menopause Stage Indicator will be available for purchase on Amazon, starting at a price of $20. This product fills a significant gap in women’s healthcare, which has often been overlooked as a subset of the overall healthcare industry. Aging individuals entering menopause, in particular, face challenges in finding suitable solutions. Clearblue’s entry into the menopause testing device market, leveraging its reputation in pregnancy tests, presents a promising opportunity.
Studies have shown that a substantial 73 percent of women experience menopause but do not seek treatment for their symptoms. Furthermore, the global menopause market is projected to reach a staggering $21.6 billion by 2026. With such potential growth and unmet needs, Clearblue’s Menopause Stage Indicator is well-positioned to tap into this market and provide valuable support to women navigating the complexities of menopause.